Phathom Pharmaceuticals, Inc. (PHAT)
6.92
-0.16
(-2.26%)
USD |
NASDAQ |
Oct 02, 16:00
6.935
+0.02
(+0.22%)
After-Hours: 20:00
Phathom Pharmaceuticals Market Cap : 554.08M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 554.08M |
| October 01, 2026 | 566.90M |
| September 30, 2026 | 584.51M |
| September 29, 2026 | 589.32M |
| September 28, 2026 | 588.51M |
| September 25, 2026 | 584.51M |
| September 24, 2026 | 566.90M |
| September 23, 2026 | 559.29M |
| September 22, 2026 | 621.34M |
| September 21, 2026 | 596.52M |
| September 18, 2026 | 598.92M |
| September 17, 2026 | 620.54M |
| September 16, 2026 | 615.74M |
| September 15, 2026 | 653.37M |
| September 14, 2026 | 695.01M |
| September 11, 2026 | 669.39M |
| September 10, 2026 | 670.19M |
| September 09, 2026 | 694.21M |
| September 08, 2026 | 755.06M |
| September 04, 2026 | 760.66M |
| September 03, 2026 | 724.63M |
| September 02, 2026 | 741.45M |
| September 01, 2026 | 751.86M |
| August 31, 2026 | 766.27M |
| August 28, 2026 | 735.04M |
| Date | Value |
|---|---|
| August 27, 2026 | 715.83M |
| August 26, 2026 | 702.21M |
| August 25, 2026 | 704.62M |
| August 24, 2026 | 693.41M |
| August 21, 2026 | 710.22M |
| August 20, 2026 | 688.60M |
| August 19, 2026 | 746.25M |
| August 18, 2026 | 740.65M |
| August 17, 2026 | 743.05M |
| August 14, 2026 | 767.07M |
| August 13, 2026 | 735.04M |
| August 12, 2026 | 734.24M |
| August 11, 2026 | 681.40M |
| August 10, 2026 | 686.20M |
| August 07, 2026 | 684.60M |
| August 06, 2026 | 671.79M |
| August 05, 2026 | 658.98M |
| August 04, 2026 | 676.59M |
| August 03, 2026 | 719.03M |
| July 31, 2026 | 700.61M |
| July 30, 2026 | 723.03M |
| July 29, 2026 | 932.01M |
| July 28, 2026 | 933.62M |
| July 27, 2026 | 956.84M |
| July 24, 2026 | 908.82M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.658B |
| Corcept Therapeutics, Inc. | 12.54B |
| Veru, Inc. | 42.80M |
| Johnson & Johnson | 616.58B |
| Eli Lilly & Co. | 1.076T |
Market Cap Related Metrics
| PS Ratio | 2.260 |
| Price | 6.92 |
| Earnings Yield | -18.42% |